Activity of granzyme A, a serine protease in the killing granules of cytotoxic T lymphocytes, is reduced in cells from HIV-infected hemophiliacs

AIDS Research and Human Retroviruses

Volumn 12, Issue 3, 1996, Pages 235-239

  Chiang, Cheng Feng ^a   Tenenbaum, Scott A ^b   Verret, C Reynold ^c   Leissinger, Cindy A ^b   Garry, Robert F ^b  

^a Tulane University   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; ESTER DERIVATIVE; SERINE PROTEINASE;

ARTICLE; CELL GRANULE; CELL KILLING; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; ENZYME SUBSTRATE; FLOW CYTOMETRY; HEMOPHILIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030020110     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.235     Document Type: Article

References (25)

1. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, and Schooley RT: HIV-specific cytotoxic T-lymphocytes in seropositive individuals. Nature (London) 1987;328:345-348.
2. Koup RA, Safrit JT, Cao Y, Andrews CA, Mcleod G, Borkowsky W, Farthing C, and Ho DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655.
3. Mackewicz CE, Yang LC, Lifson JD, and Levy JA: Non-cytolyic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 1994;344:1671-1673.
4. Pantaleo G, Demarest JF, Soudeynes H, Graziosi C, Denis F, Adeisberger JW, Borrow P, Saag MS, Shaw G, Sekaly RP, and Fauci AS: Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature (London) 1994;370:463-467.
5. Birx DL, Redfield RR, and Tosato R: Defective regulation of Epstein-Barr virus infection in patients with acquired immune deficiency syndrome or AIDS-related disorders. N Engl J Med 1986;314:874-879.
6. Rook AH, Manischewitz JF, and Frederick WR: Deficient HLA-restricted cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immune deficiency syndrome. J Infect Dis 1985;152:627-630.
7. Lewis DE, Tang DS, Adu-Oppong A, Schober W, and Rodgers JR: Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 1994;153:412-420.
8. Henkart PA: Mechanism of lymphocyte-mediated cytotoxicity. Annu Rev Immunol 1985;3:31-58.
9. Pasternack MS, Verret CR, Liu MA, and Eisen HN: Serine esterase in cytolytic T-lymphocytes. Nature (London) 1986;322:740-743.
10. Hudig D, Ewoldt GR, and Woodard SL: Proteases and lymphocyte cytotoxic killing mechanisms. Curr Opin Immunol 1993;5:90-96.
11. Pasternack MS and Eisen HN: A novel serine esterase expressed by cytotoxic T-lymphocytes. Nature (London) 1985;314:743-745.
12. Shiver JW, Su L, and Henkart PA: Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 1992;71:315-322.
13. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, and Ley TJ: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994;76:977-987.
14. Shi L, Kam C-M, Powers JC, Aebersold R, and Greenberg AH: Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 1992;176:1521-1529.
15. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Elliston KO, Ayala JM, Casano FJ, Chin J, Ding GJ-F, Egger LA, Gaffney EP, Limjuco G, Palyha OC, Raju SM, Rolando AM, Salley JP, Yamin T-T, Lee TD, Shively JE, MacCross M, Mumford RA, Schmidt JA, and Tocci MJ: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature (London) 1992;356:768-774.
16. Pasternack MS, Blier KJ, and McInerney TN: Granzyme A binding to target cell proteins. Granzyme A binds to and cleaves nucleolin in vitro. J Biol Chem 1991;266:14703-14708.
17. Burke G: The binding and lysis of target cells by cytotoxic lymphocytes: Molecular and cellular aspects. Annu Rev Immunol 1994;12:735-773.
18. Hameed A, Lowrey DM, Lichtenheld M, and Podack ER: Characterization of three serine esterases isolated from human IL-2 activated killer cells. J Immunol 1988;141:3142-3147.
19. Smyth MJ and Trapani JA: Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995;16:202-206.
20. Moretta A: Frequency and surface phenotype of human T lymphocytes producing interleukin 2: Analysis by limiting dilution and cell cloning. Eur J Immunol 1985;15:148-155.
21. Laurent-Crawford AG, Krust B, Muller S, Riviere Y, Rey-Cuille MA, Bechet JM, Montagnier L, and Hovanessian AG: The cytopathic effect of HIV is associated with apoptosis. Virology 1991;185:829-839.
22. Terai C, Kornbluth RS, Pauza CD, Richman DD, and Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991;87:1710-1715.
23. Bajpai A, Kwon BS, and Brahmi Z: Rapid loss of perform and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets. Immunology 1991;74:258-263.
24. Dalgleish AG: The pathogenesis of AIDS: Classical and alternative views. J R Coll Physicians Lond 1992;26:152-158.
25. Lipman ML, Stevens AC, and Strom TB: Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994;152:5120-5127.